Established WDCP as a clinically relevant oncogenic locus by identifying it as a recurrent ALK fusion partner in colorectal cancer, raising the question of how a poorly characterized ORF could drive kinase activation.
Evidence Next-generation sequencing of colorectal tumor specimens
- Oncogenic mechanism inferred from fusion architecture but not reconstituted in vitro
- Native function of WDCP not addressed
- Frequency and clinical impact across cohorts not defined here